HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity.

Publication Type Academic Article
Authors Migueles S, Nettere D, Gavil N, Wang L, Toulmin S, Kelly E, Ward A, Lin S, Thompson S, Peterson B, Abdeen C, Sclafani C, Pryal P, Leach B, Ludwig A, Rogan D, Przygonska P, Cattani A, Imamichi H, Sachs A, Cafri G, Huang N, Patamawenu A, Liang C, Hallahan C, Kambach D, Han E, Coupet T, Chen J, Moir S, Chun T, Coates E, Ledgerwood J, Schmidt J, Taillandier-Coindard M, Michaux J, Pak H, Bassani-Sternberg M, Frahm N, McElrath M, Connors M
Journal Science
Volume 382
Issue 6676
Pagination 1270-1276
Date Published 12/14/2023
ISSN 1095-9203
Keywords AIDS Vaccines, HIV Infections, Cytotoxicity, Immunologic, T-Lymphocytes, Cytotoxic, Cell Degranulation
Abstract Current HIV vaccines designed to stimulate CD8+ T cells have failed to induce immunologic control upon infection. The functions of vaccine-induced HIV-specific CD8+ T cells were investigated here in detail. Cytotoxic capacity was significantly lower than in HIV controllers and was not a consequence of low frequency or unaccumulated functional cytotoxic proteins. Low cytotoxic capacity was attributable to impaired degranulation in response to the low antigen levels present on HIV-infected targets. The vaccine-induced T cell receptor (TCR) repertoire was polyclonal and transduction of these TCRs conferred the same reduced functions. These results define a mechanism accounting for poor antiviral activity induced by these vaccines and suggest that an effective CD8+ T cell response may require a vaccination strategy that drives further TCR clonal selection.
DOI 10.1126/science.adg0514
PubMed ID 38096385
Back to Top